Silo Pharma, Inc. Common Stock

SILONASDAQUSD
2.74 USD
0.12 (4.20%)AT CLOSE (11:59 AM EDT)
2.72
0.02 (0.73%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
2.72
0.02 (0.73%)
🟢Market: OPEN

Shares of Silo Pharma, Inc. Common Stock (SILO) are trading at $2.72. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place SILO at a fair price relative to peers.

Technical & fundamental data as of Aug 20, 2026.

Open?$2.80
High?$2.82
Low?$2.70
Prev. Close?$2.86
Volume?32.8K
Avg. Volume?148.6K
VWAP?$2.76
Rel. Volume?0.22x
Bid / Ask
Bid?$2.33 × 100
Ask?$3.30 × 100
Spread?$0.97
Midpoint?$2.82
Valuation & Ratios
Market Cap?4.5M
Shares Out?1.3M
Float?15.2M
Float %?93.1%
P/E Ratio?N/A
P/B Ratio?0.93
EPS?-$2.82
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Employees
3
Market Cap
4.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2012-01-05
Address
677 N. WASHINGTON BLVD
SARASOTA, FL 34236
Phone: (718) 400-9031
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.14Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.84%Low
Short Interest?126.5K
Days to Cover?5.6
Free Float15.2M
Avg Daily Volume22.5K
Settlement Date2026-07-31
Financial Health
Current Ratio?5.36Strong
Quick Ratio?5.36Strong
Cash Ratio?3.07Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.93CHEAP
P/S?
Peers
100
S&P
3
84.00HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.3CHEAP
EV/Sales?
Peers
100
S&P
3
23.40HIGH
Returns & Efficiency
ROE?
S&P
3
-91.5%WEAK
ROA?
S&P
3
-75.1%WEAK
Cash Flow & Enterprise
FCF?$-3385443
Enterprise Value?$1.3M
Fundamentals ratios updated end of day